| 英文名稱 |
中文名稱 |
CAS號 |
操作 |
| Nicotine Related Compound A |
新煙草堿(去氫新煙堿) |
2743-90-0 |
詳細(xì)
|
| Settleable Solids - WP |
|
|
詳細(xì)
|
| Anti-LIMK2 antibody produced in rabbit |
|
|
詳細(xì)
|
| Anti-CDK5RAP1, (N-terminal) antibody produced in rabbit |
|
|
詳細(xì)
|
| N-(4-FLUOROBENZYLIDENE)-PARA-TOLUIDINE |
N-(4-FLUOROBENZYLIDENE)-PARA-TOLUIDINE |
39769-11-4 |
詳細(xì)
|
| 2-AMINO-4-(2-NITRO-PHENYL)-5-OXO-5,6,7,8-TETRAHYDRO-4H-CHROMENE-3-CARBONITRILE |
|
315245-18-2 |
詳細(xì)
|
| 2-Cyclohepten-1-one |
2-環(huán)庚烯-1-酮 |
1121-66-0 |
詳細(xì)
|
| LN6TF-C3-biot |
|
|
詳細(xì)
|
| 2-(METHYLTHIO)BENZOXAZOLE |
2-甲巰基苯并惡唑 |
13673-62-6 |
詳細(xì)
|
| Mounting Kit |
|
|
詳細(xì)
|
| PrEST Antigen TBC1D10B |
|
|
詳細(xì)
|
| KL201 |
化合物KL201 |
302939-48-6 |
詳細(xì)
|
| 1,4-Cyclohexanedimethanol divinyl ether, mixture of isomers |
1,4-環(huán)己烷二甲醇二乙烯醚 |
17351-75-6 |
詳細(xì)
|
| 5-Bromo-2-methoxybenzenesulfonyl chloride |
5-溴-2-甲氧基苯磺酰氯 |
23095-05-8 |
詳細(xì)
|
| N'-[(E)-(5-BROMO-2-METHOXYPHENYL)METHYLIDENE]-2-(3-METHYL-5-OXO-4,5-DIHYDRO-1H-PYRAZOL-4-YL)ACETOHYDRAZIDE |
|
306952-54-5 |
詳細(xì)
|
| ETHYL 8-BROMO-8-NITROOCTANOATE |
|
13154-51-3 |
詳細(xì)
|
| Cover for Milliflex Oasis VHP resistant pump, internal flow sanitization kit |
|
|
詳細(xì)
|
| ANTI-SIGLEC15 (C-TERM) antibody produced in rabbit |
SIGLEC-15 |
|
詳細(xì)
|
| ORBO Tube Cutter |
|
|
詳細(xì)
|
| 1-(4-ME-PH)-2-((4-(4-ME-PH)-5-(4-PYRIDINYL)-4H-1,2,4-TRIAZOL-3-YL)THIO)ETHANONE |
|
338426-00-9 |
詳細(xì)
|
| 5-(4-CHLOROBENZYLIDENE)-2-PHENYL(1,3)THIAZOLO(3,2-B)(1,2,4)TRIAZOL-6(5H)-ONE |
|
58755-11-6 |
詳細(xì)
|
| 4-(2-((4-ETHYLANILINO)(OXO)ACETYL)CARBOHYDRAZONOYL)PHENYL 4-ETHOXYBENZOATE |
|
769148-49-4 |
詳細(xì)
|
| Octaethylene glycol monohexadecyl ether |
聚辛乙二醇單十六醚 |
5698-39-5 |
詳細(xì)
|
| Monoclonal Anti-CTGF antibody produced in mouse |
|
|
詳細(xì)
|
| 6-NITROCHOLESTERYL BENZOATE |
|
|
詳細(xì)
|
| 2-chloro-N-[(2E)-2-pyrrolidinylidene]-3-pyridinamine hydrochloride |
|
|
詳細(xì)
|
| Monoclonal Anti-IL4, (C-terminal) antibody produced in mouse |
|
|
詳細(xì)
|
| 4-(3-FLUORO-4-METHOXYBENZOYL)-3-HYDROXY-5-(4-PYRIDINYL)-1-(3-PYRIDINYLMETHYL)-1,5-DIHYDRO-2H-PYRROL-2-ONE |
|
618074-69-4 |
詳細(xì)
|
| Anti-A,B (clones ES-15/ES-4), Blood Grouping Reagent |
|
|
詳細(xì)
|
| Hyocholic acid |
豬膽酸 |
547-75-1 |
詳細(xì)
|
| Diphenhydramine Citrate |
苯海拉明檸檬酸鹽 |
88637-37-0 |
詳細(xì)
|
| PrEST Antigen RTN2 |
|
|
詳細(xì)
|
| Phospholipase C Activator, m-3M3FBS |
2,4,6-三甲基-N-[3-(三氟甲基)苯基]苯磺酰胺 |
200933-14-8 |
詳細(xì)
|
| Anti-SPEN antibody produced in rabbit |
|
|
詳細(xì)
|
| 1-(4-(4-Chlorobenzyloxy)-2-hydroxyphenyl)-2-(4-chlorophenyl)ethanone |
|
925007-31-4 |
詳細(xì)
|
| 5-ALPHA-CHOLESTAN-1-BETA-OL |
|
|
詳細(xì)
|
| N'-(2-FURYLMETHYLENE)-2-(2-THIENYL)ACETOHYDRAZIDE |
|
290366-55-1 |
詳細(xì)
|
| hBFGF |
成纖維細(xì)胞生長因子 |
106096-93-9 |
詳細(xì)
|
| Monoclonal Anti-AMID antibody produced in mouse |
|
|
詳細(xì)
|
| Anti-phospho-PKD2 (pSer876) antibody produced in rabbit |
|
|
詳細(xì)
|
| Anti-SSRP1 antibody produced in rabbit |
|
|
詳細(xì)
|
| 2-F-N-(2,2,2-TRICHLORO-1-(3-(2-CL-5-TRIFLUORO-ME-PH)-THIOUREIDO)-ET)-ACETAMIDE |
|
301813-60-5 |
詳細(xì)
|
| 1-(2-(DIMETHYLAMINO)ETHYL)-3-PHENYL-2,4,5-IMIDAZOLIDINETRIONE |
|
883799-33-5 |
詳細(xì)
|
| Anti-PGK1 antibody produced in rabbit |
|
|
詳細(xì)
|
| 3-Bromo-5-(2-hydroxyethyl)isoxazole |
3-溴-5-(2-羥乙基)異惡唑 |
105175-00-6 |
詳細(xì)
|
| N-(2-(2-(4-(DIMETHYLAMINO)BENZYLIDENE)HYDRAZINO)-2-OXOETHYL)-4-FLUOROBENZAMIDE |
|
324032-47-5 |
詳細(xì)
|
| 5-FLUORO-2-(4-FLUORO-BENZYL)-ISOINDOLE-1,3-DIONE |
|
351996-28-6 |
詳細(xì)
|
| (METHOXYCARBONYLAMINO-(4-METHOXY-PHENYL)-METHYL)-CARBAMIC ACID METHYL ESTER |
|
303061-60-1 |
詳細(xì)
|
| Xanthene |
氧雜蒽 |
92-83-1 |
詳細(xì)
|
| Anti-ORAI2 antibody produced in rabbit |
|
|
詳細(xì)
|
| 9-CHLORO-2-(4-CHLOROPHENYL)-1,10B-DIHYDROSPIRO[BENZO[E]PYRAZOLO[1,5-C][1,3]OXAZINE-5,1'-CYCLOHEXANE] |
|
332060-48-7 |
詳細(xì)
|
| Anti-ZKSCAN4 antibody produced in rabbit |
|
|
詳細(xì)
|
| 4-(2,4-DIMETHYLPHENYL)-5-PHENYL-4H-1,2,4-TRIAZOLE-3-THIOL |
|
334501-13-2 |
詳細(xì)
|
| 1-(4-AMINO-1,2,5-OXADIAZOL-3-YL)-N'-[(Z)-1-[1,1'-BIPHENYL]-4-YLETHYLIDENE]-5-[(2-METHYL-1-PIPERIDINYL)METHYL]-1H-1,2,3-TRIAZOLE-4-CARBOHYDRAZIDE HYDROCHLORIDE |
|
1173010-95-1 |
詳細(xì)
|
| ISOPROPYL 5-(9H-PURIN-6-YLTHIO)PENTANOATE |
|
10389-90-9 |
詳細(xì)
|
| 1-((1S,5R)-5-{[TERT-BUTYL(DIPHENYL)SILYL]OXY}-2-CYCLOPENTEN-1-YL)-3-PENTYN-2-OL |
|
1217521-49-7 |
詳細(xì)
|
| Anti-EIF4E3 antibody produced in rabbit |
|
|
詳細(xì)
|
| 4-(2-((1-NAPHTHYLOXY)ACETYL)CARBOHYDRAZONOYL)PHENYL 3-BROMOBENZOATE |
|
302910-43-6 |
詳細(xì)
|
| Anti-ANKRD24 antibody produced in rabbit |
|
|
詳細(xì)
|
| RCL S120138 |
|
1037840-20-2 |
詳細(xì)
|
| N-((2-ETHOXY-1-NAPHTHYL)METHYLENE)-2-ETHYLANILINE |
|
1429788-68-0 |
詳細(xì)
|
| 4-isopropylbenzohydrazide |
4-異丙基苯甲酰肼 |
5351-24-6 |
詳細(xì)
|
| 6-METHYL-7-PHENYL-5H-PYRROLO[2,3-B]PYRAZINE |
|
56015-25-9 |
詳細(xì)
|
| Clozapine N-oxide hydrochloride |
氯氮平-N-氧化物 |
34233-69-7 |
詳細(xì)
|
| Corning LSE Digital Vortexer Platform For Four Microplates |
|
|
詳細(xì)
|
| 5-NAPHTHALEN-2-YL-2H-PYRAZOLE-3-CARBOXYLIC ACID (3-PHENYL-ALLYLIDENE)-HYDRAZIDE |
|
306301-85-9 |
詳細(xì)
|
| Methyltrioctylammonium chloride |
甲基三辛基氯化銨 |
5137-55-3 |
詳細(xì)
|
| Anti-ITGA8 antibody produced in rabbit |
|
|
詳細(xì)
|
| Anti-PHACTR2 antibody produced in rabbit |
|
|
詳細(xì)
|
| Anti-Potassium Channel TREK-1 Antibody |
|
|
詳細(xì)
|
| TAO1 Protein, active, 10 μg |
|
|
詳細(xì)
|
| 2,4,6-Trimethylaniline |
均三甲苯胺 |
88-05-1 |
詳細(xì)
|
| 2-CL-N'-(4-MEO-3-((3-NITRO-1H-1,2,4-TRIAZOL-1-YL)ME)BENZYLIDENE)BENZOHYDRAZIDE |
|
883826-07-1 |
詳細(xì)
|
| 5-Lipoxygenase, Human, Recombinant, S. fruigiperda |
|
|
詳細(xì)
|
| 2-IMINO-N-(3-METHOXYPROPYL)-10-METHYL-1-[2-(4-MORPHOLINYL)ETHYL]-5-OXO-1,5-DIHYDRO-2H-DIPYRIDO[1,2-A:2,3-D]PYRIMIDINE-3-CARBOXAMIDE |
|
618383-67-8 |
詳細(xì)
|
| SCHU human cell line |
|
|
詳細(xì)
|
| N-(4-SEC-BUTYLPHENYL)-2-FURAMIDE |
|
329939-27-7 |
詳細(xì)
|
| Anti-Rabbit set(AP187P/2170/WBKL500ml |
|
|
詳細(xì)
|
| RCL L210277 |
|
1005189-03-6 |
詳細(xì)
|
| 1-benzyl-4-phenyl-1H-1,2,3-triazol-5-amine |
1-芐基-4-苯基-1H-1,2,3-三唑-5-胺 |
32515-07-4 |
詳細(xì)
|
| N'-(4-HO-3-METHOXYBENZYLIDENE)-3-(4-ISOBUTYLPHENYL)-1H-PYRAZOLE-5-CARBOHYDRAZIDE |
|
403659-35-8 |
詳細(xì)
|
| MScn Vac Mnfld Pump Kit-100V,50-60Hz |
|
|
詳細(xì)
|
| ETHYL 4-METHYL-2-{[(1-NAPHTHYLOXY)ACETYL]AMINO}-5-(2-TOLUIDINOCARBONYL)-3-THIOPHENECARBOXYLATE |
|
518349-83-2 |
詳細(xì)
|
| (2-ALLYLCYCLOHEXYLIDENE)ACETIC ACID, CYCLOHEXYLAMINE SALT |
|
111946-01-1 |
詳細(xì)
|
| ETHYL 5-{[(3-ALLYL-4-OXO-5-PHENYL-3,4-DIHYDROTHIENO[2,3-D]PYRIMIDIN-2-YL)SULFANYL]ACETYL}-2,4-DIMETHYL-1H-PYRROLE-3-CARBOXYLATE |
|
315710-53-3 |
詳細(xì)
|
| 1,2-di(1H-benzimidazol-2-yl)-1,2-ethanediol |
1,2-雙(1H-苯并咪唑-2-基)乙烷-1,2-二醇 |
3314-32-7 |
詳細(xì)
|
| 2(4,5-DI-PH-4H(1,2,4)TRIAZOL-3-YLSULFANYL)ACETIC ACID (1-PH-ETHYLIDENE)HYDRAZIDE |
|
303204-65-1 |
詳細(xì)
|
| N-(3-CHLORO-4-METHYLPHENYL)-2-{[5-(4-CHLOROPHENYL)-4-(4-METHYLPHENYL)-4H-1,2,4-TRIAZOL-3-YL]SULFANYL}ACETAMIDE |
|
477330-99-7 |
詳細(xì)
|
| 4-ETHOXYBENZALDEHYDE [1,3-DIMETHYL-7-(4-METHYLBENZYL)-2,6-DIOXO-2,3,6,7-TETRAHYDRO-1H-PURIN-8-YL]HYDRAZONE |
|
536718-58-8 |
詳細(xì)
|
| ETHYL 2-{[((2E)-2-{5-BROMO-2-[(4-ETHOXYBENZOYL)OXY]BENZYLIDENE}HYDRAZINO)(OXO)ACETYL]AMINO}-6-METHYL-4,5,6,7-TETRAHYDRO-1-BENZOTHIOPHENE-3-CARBOXYLATE |
|
883569-02-6 |
詳細(xì)
|
| ETHYL 6-(3-FLUOROPHENYL)-8-METHYL-4-OXO-3,4-DIHYDRO-2H,6H-PYRIMIDO[2,1-B][1,3]THIAZINE-7-CARBOXYLATE |
|
618075-73-3 |
詳細(xì)
|
| N-(2-BROMOBENZYLIDENE)-4-(2,4-DIMETHYLBENZYL)-1-PIPERAZINAMINE |
|
315185-06-9 |
詳細(xì)
|
| (2-(2-AMINOANILINO)-1-((4-ME-BENZOYL)AMINO)VINYL)(TRI-PH)PHOSPHONIUM PERCHLORATE |
|
1265910-28-8 |
詳細(xì)
|
| Aluminum cerium oxide |
鋁酸鈰 |
12014-44-7 |
詳細(xì)
|
| 2-{[4-ALLYL-5-(2-PYRIDINYL)-4H-1,2,4-TRIAZOL-3-YL]SULFANYL}-N-[4-(DIETHYLAMINO)PHENYL]ACETAMIDE |
|
618880-20-9 |
詳細(xì)
|
| 1-[2-(DIETHYLAMINO)ETHYL]-3-HYDROXY-5-(4-HYDROXY-3-METHOXYPHENYL)-4-(4-ISOBUTOXY-2-METHYLBENZOYL)-1,5-DIHYDRO-2H-PYRROL-2-ONE |
|
488706-66-7 |
詳細(xì)
|
| 1-(5-nitro-2-thienyl)piperidine |
|
19991-84-5 |
詳細(xì)
|
| 1-(5-Methyl-1H-pyrazol-4-yl)ethanone |
105224-04-2 |
105224-04-2 |
詳細(xì)
|
| 1-DODECYLOXYCARBONYLMETHYL-3-(METHYLCARBAMOYL)-PYRIDINIUM CHLORIDE |
|
112746-29-9 |
詳細(xì)
|
| Park and Sanders Selective Supplement II |
PARK 和 SANDERS 選擇性添加劑 II |
|
詳細(xì)
|